CLINICAL_TRIALS ClinicalTrials.gov record update

Expanded Access Program of OFEV® (Nintedanib) in Children and Adolescents (6- to 17-year-old) With Clinically Significant Fibrosing Interstitial Lung Disease (ILD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05624281
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:22.511866+00:00
Published At: 2024-01-12T00:00:00+00:00
Record Updated At: 2024-01-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lung Diseases, Interstitial (in Pediatric Populations)", "Childhood Interstitial Lung Disease (chILD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-01-12"
protocolSection.identificationModule.nctId: "NCT05624281"
protocolSection.identificationModule.officialTitle: "Expanded Access Program of OFEV\u00ae (Nintedanib) in Children and Adolescents (6- to 17-year-old) With Clinically Significant Fibrosing Interstitial Lung Disease (ILD)"
protocolSection.statusModule.overallStatus: "NO_LONGER_AVAILABLE"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.